These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8542269)

  • 1. Prospects for using a blood sample in the diagnosis of heart failure.
    Cheung BM
    QJM; 1995 Nov; 88(11):845; author reply 846. PubMed ID: 8542269
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for using a blood sample in the diagnosis of heart failure.
    Ulahannan TJ
    QJM; 1995 Nov; 88(11):845-6. PubMed ID: 8542270
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B-type natriuretic peptide in the differential diagnosis of dyspnea: a useful aid or meaningless ornament? (see the article by Stejskal D. et al: "Personal experience with determination of NT-proBNP in clinical practice" in this issue of Vnitrní Lékarství].
    Kölbel F
    Vnitr Lek; 2003 Feb; 49(2):94-6. PubMed ID: 12728574
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D; Oral I; Lacnák B; Juráková R; Horalík D; Adamovská S; Prosková J; Hrabovská I; Ozanová G
    Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chim Acta; 2004 Mar; 341(1-2):41-8. PubMed ID: 14967157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of NT-PRO-BNP in end stage renal failure patients].
    Heras M; Fernández Reyes MJ; Guevara P; Sánchez R; González M; Velasco S; García Arévalo MC; Alvarez-Ude F
    Nefrologia; 2005; 25(6):698-702. PubMed ID: 16514911
    [No Abstract]   [Full Text] [Related]  

  • 12. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension.
    Conen D; Zeller A; Pfisterer M; Martina B
    Am J Cardiol; 2006 Jan; 97(2):249-52. PubMed ID: 16442372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide (BNP) or N-terminal-proBNP for the diagnosis of heart failure: which peptide is the better choice?
    Kragelund C; Omland T
    Scand J Clin Lab Invest; 2005; 65(8):629-32. PubMed ID: 16319037
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?
    Struthers AD
    Br Heart J; 1993 Nov; 70(5):397-8. PubMed ID: 8260266
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac hormones: diagnostic and therapeutic potential.
    Lainchbury JG; Espiner EA; Nicholls MG; Richards AM
    N Z Med J; 1997 Jun; 110(1046):219-21. PubMed ID: 9236802
    [No Abstract]   [Full Text] [Related]  

  • 16. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
    Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H
    Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.
    Andersen NH; Poulsen SH; Knudsen ST; Heickendorff L; Mogensen CE
    Diabet Med; 2005 Feb; 22(2):188-95. PubMed ID: 15660737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart failure. Diagnosis and prognosis readable from a simple blood test].
    MMW Fortschr Med; 2004 Mar; 146(11):59. PubMed ID: 15152779
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain natriuretic peptide in heart failure and beyond.
    Mowla MM; Bustami BB
    Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.